Skip Navigation

European Heart Journal 2004 25(21):1967; doi:10.1016/j.ehj.2004.05.030
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Karagiannis, A.
Right arrow Articles by Zamboulis, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karagiannis, A.
Right arrow Articles by Zamboulis, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letter to the editor

Plasma B-type natriuretic peptide is related to left ventricular mass in hypertensive patients

Asterios Karagiannis*, Konstantinos Tziomalos1 and Chrysanthos Zamboulis

Second Propedeutic Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, 63 Solonos Street, 54248 Thessaloniki, Greece

Received May 7, 2004; accepted May 26, 2004 * Corresponding author. Tel.: +30 2310892058; fax: +30 2310992834 (E-mail: ktziomalos@yahoo.com).

The first 10% of the full text of this article appears below.

Dear Editor,

We read with great interest the paper by Cowie et al., on clinical applications of B-type natriuretic peptide (BNP) testing.1 Atrial (ANP) and B-type natriuretic peptide are peptide hormones released in response to myocyte stretch. Novel biomarkers have been evaluated for four . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?